Bülent Antmen

1.7k total citations
56 papers, 408 citations indexed

About

Bülent Antmen is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bülent Antmen has authored 56 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 13 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bülent Antmen's work include Hemophilia Treatment and Research (17 papers), Hemoglobinopathies and Related Disorders (8 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Bülent Antmen is often cited by papers focused on Hemophilia Treatment and Research (17 papers), Hemoglobinopathies and Related Disorders (8 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Bülent Antmen collaborates with scholars based in Türkiye, Italy and United States. Bülent Antmen's co-authors include M. Yılmaz, M. Cenk Haytaç, Derya Ufuk Altıntaş, Seval Güneşer Kendirli, İlgen Şaşmaz, Melek Ergin, Hatice Şaşmaz, Atila Tanyeli, Filiz Can and Gülşah Şeydaoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Periodontology.

In The Last Decade

Bülent Antmen

48 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bülent Antmen Türkiye	12	234	66	51	51	46	56	408
Halûk Demiroğlu Türkiye	11	253 1.1×	56 0.8×	74 1.5×	68 1.3×	40 0.9×	75	551
Jacek M. Polski United States	13	225 1.0×	49 0.7×	100 2.0×	28 0.5×	47 1.0×	24	414
NM Wulffraat Netherlands	10	193 0.8×	72 1.1×	30 0.6×	31 0.6×	46 1.0×	31	382
Kazutoshi Koike Japan	12	157 0.7×	36 0.5×	45 0.9×	45 0.9×	28 0.6×	35	337
Gislaine Borba Oliveira Brazil	12	215 0.9×	56 0.8×	72 1.4×	28 0.5×	66 1.4×	28	395
R Destro Italy	10	223 1.0×	57 0.9×	81 1.6×	31 0.6×	51 1.1×	19	419
Young Tak Lim South Korea	13	174 0.7×	23 0.3×	67 1.3×	55 1.1×	88 1.9×	43	412
Ayşegül Ünüvar Türkiye	13	135 0.6×	66 1.0×	40 0.8×	75 1.5×	118 2.6×	55	436
Manjusha Kumar United States	13	163 0.7×	25 0.4×	49 1.0×	20 0.4×	73 1.6×	19	310
Ah Moy Tan Singapore	14	181 0.8×	103 1.6×	54 1.1×	60 1.2×	58 1.3×	50	542

Countries citing papers authored by Bülent Antmen

Since Specialization

Citations

This map shows the geographic impact of Bülent Antmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bülent Antmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bülent Antmen more than expected).

Fields of papers citing papers by Bülent Antmen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bülent Antmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bülent Antmen. The network helps show where Bülent Antmen may publish in the future.

Co-authorship network of co-authors of Bülent Antmen

This figure shows the co-authorship network connecting the top 25 collaborators of Bülent Antmen. A scholar is included among the top collaborators of Bülent Antmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bülent Antmen. Bülent Antmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leavitt, Andrew D., Kaan Kavaklı, Laurent Frenzel, et al.. (2024). Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial. Blood. 144(Supplement 1). 1053–1053. 2 indexed citations

Kenet, Gili, Beatrice Nolan, Bülent Zülfikar, et al.. (2024). Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood. 143(22). 2256–2269. 16 indexed citations

Şaşmaz, İlgen, et al.. (2024). The Efficacy of Three Different Oral Hygiene Regimens in Preventing Chemotherapy-Induced Oral Mucositis in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation. Klinische Pädiatrie. 236(3). 180–188.

Locatelli, Franco, Bülent Antmen, Hyoung Jin Kang, et al.. (2024). Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study. The Lancet Haematology. 11(8). e580–e592. 4 indexed citations

Şaşmaz, Hatice, et al.. (2024). Clinical and Radiological Characteristics of Classical and Variant Type of Posterior Reversible Encephalopathy Syndrome on Prognosis Following Hematopoietic Stem Cell Transplantation in Pediatric Patients: A Single-Center Experience.. Experimental and Clinical Transplantation. 22(10). 800–809.

Şaşmaz, İlgen, et al.. (2024). The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem‐cell transplantations: A single‐center experience. Clinical Transplantation. 38(5). e15366–e15366. 1 indexed citations

Baronciani, D, Josu de la Fuente, Arnaud Dalissier, et al.. (2024). Age Is a Crucial Determinant of GFRS with Incidence of Severe Chronic GVHD Reducing over Time in Haemopoietic Cell Transplantation for Transfusion Dependent Thalassaemia: Real World Data from 2010-2021. an Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party. Blood. 144(Supplement 1). 2136–2136. 1 indexed citations

Antmen, Bülent, Satheesh Chonat, Lucia De Franceschi, et al.. (2023). Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease. Blood. 142(Supplement 1). 1158–1158.

Kenet, Gili, Beatrice Nolan, Bülent Zülfikar, et al.. (2023). S303: A PHASE 3 STUDY (ATLAS-PPX) TO EVALUATE EFFICACY AND SAFETY OF FITUSIRAN IN PEOPLE WITH HAEMOPHILIA A OR B WHO HAVE SWITCHED FROM PRIOR CLOTTING FACTOR CONCENTRATE OR BYPASSING AGENT PROPHYLAXIS. HemaSphere. 7(S3). e643526e–e643526e. 2 indexed citations

10.

Şaşmaz, Hatice, et al.. (2023). PEDİATRİK HEMATOLOJİ-ONKOLOJİ HASTALARININ EBEVEYNLERİNİN KAYGI YÜKÜNÜN İNCELENMESİ. DergiPark (Istanbul University). 24(1). 77–82. 1 indexed citations

11.

Sidonio, Robert F., Christine Knoll, Flora Peyvandi, et al.. (2021). Immunogenicity, Efficacy and Safety of Rurioctocog Alfa Pegol in Previously Untreated Patients with Severe Hemophilia a: Interim Results from an Open-Label Multicenter Clinical Trial. Blood. 138(Supplement 1). 3184–3184. 3 indexed citations

12.

Can, Filiz, et al.. (2020). Muscle strength and joint health in children with hemophilia: a cross-sectional study. The Turkish Journal of Pediatrics. 62(4). 606–613. 3 indexed citations

13.

Antmen, Bülent, et al.. (2019). Serum Fas and Fas Ligand levels in childhood acute lymphoblastic leukemias. DergiPark (Istanbul University). 44(4). 1400–1404. 1 indexed citations

14.

Antmen, Bülent, et al.. (2017). Direct Medical Care Cost Associated with β-Thalassemia Care in Turkey. Blood. 130. 2094–2094. 3 indexed citations

15.

Özçelik, Onur, M. Cenk Haytaç, Melek Ergin, Bülent Antmen, & Gülşah Şeydaoğlu. (2008). The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 105(4). 481–485. 20 indexed citations

16.

Şaşmaz, İlgen, et al.. (2006). CARDIAC MUCORMYCOSIS IN A CHILD WITH SEVERE APLASTIC ANEMIA: A Case Report. Pediatric Hematology and Oncology. 23(5). 433–437. 5 indexed citations

17.

Haytaç, M. Cenk, et al.. (2003). Severe Alveolar Bone Loss and Gingival Hyperplasia as Initial Manifestation of Burkitt Cell Type Acute Lymphoblastic Leukemia. Journal of Periodontology. 74(4). 547–551. 11 indexed citations

18.

Kılınç, Yurdanur, İlgen Şaşmaz, Abdi Bozkurt, Bülent Antmen, & Esmeray Acartürk. (2003). Effect of the radiographic contrast material iopamidol on hemostasis: an observational study in thirty cardiac patients. Current Therapeutic Research. 64(7). 461–472. 1 indexed citations

19.

Yılmaz, M., et al.. (2001). Cytokine Levels in Serum of Patients with Juvenile Rheumatoid Arthritis. Clinical Rheumatology. 20(1). 30–35. 77 indexed citations

20.

Antmen, Bülent, et al.. (1996). The frequency of IgG subclass deficiency in children with recurrent respiratory infections.. PubMed. 38(2). 161–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact